In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

By Nancy Lapid (Reuters) -Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported ...

Stem cell therapy has restored insulin production in about 10 patients with Type 1 diabetes, according to a study published ...

While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Fatty liver disease and type 2 diabetes are closely linked, exacerbating each other through insulin resistance and metabolic ...

Researchers have bioprinted human islets designed to mimic the body’s own tissue structure, allowing them to integrate ...

Using a hybrid, closed-loop insulin delivery system in the auto mode shows improved glycemic control and a favorable safety ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.